12 month data from The PRECISE Trial, the first global, prospective, randomized trial comparing diagnosis and evaluation pathways for stable chest pain, will be presented at the AHA 2022 Scientific Sessions.
October 04, 2022
HeartFlow Announces Late Breakers Presentation at the 2022 American Heart Association (AHA) Scientific Sessions
October 4, 2022 — HeartFlow, Inc., the leader in revolutionizing precision heart care, announced that the results of…
Read More
The stage is set for the American Heart Association (AHA) Scientific Sessions 2022, to be held November 5-7 at McCormick Place in Chicago, and virtually.
October 04, 2022
AHA Scientific Sessions 2022 Program, Late-breakers Announced
October 4, 2022 — The American Heart Association (AHA) Scientific Sessions 2022 is set for November 5-7 at McCormick…
Read More
By Christine Book
October 03, 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
The 34th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular…
Read More
The Impella CP with SmartAssist heart pump is a minimally invasive, temporary heart pump that uses real-time intelligence associated with improved survival and heart recovery. (Graphic: Business Wire)
By Melinda Taschetta-Millane
October 03, 2022
Top 10: Most-read Content in September
Here is a recap of what DAIC viewers found most interesting during the month of September: 1. Unloading with Impella…
Read More
Presentations highlight the significant potential clinical benefits of managing congestion in patients with heart failure with FUROSCIX (furosemide injection) at home
October 03, 2022
scPharmaceuticals Announces Data Presentations at the Heart Failure Society of America 2022 Annual Scientific Meeting
October 3, 2022 — scPharmaceuticals Inc., a pharmaceutical company focused on developing and commercializing products…
Read More
The first-of-its-kind patch, designed to offer comfort and free movement, provides actionable reports in under 24 hours to revolutionize the detection of conditions that cost the United States $363bn annually, allowing medical institutions to save more lives and scale their practice
October 03, 2022
Mawi launches Mawi Heart Patch
October 3, 2022 — Mawi, creators of AI-powered wearable medical devices for cardiac disease diagnostic and monitoring,…
Read More
The new ECHO lab enables cardiac teams to use ultrasound (or echocardiography) to assess the size and efficiency of heart chambers. Stress tests, coronary CTAs, and cardiac MRIs are also interpreted there.
October 03, 2022
Memorial Cardiac and Vascular Institute Battling Heart Disease in a New Place
October 3, 2022 — A new ‘ECHO lab’ at Memorial Hospital West is benefiting patients that may have heart disease and the…
Read More
September 29, 2022
HeartBeam Granted Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)
September 29, 2022 —  HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ECG…
Read More
Researchers at Mayo Clinic used artificial intelligence (AI) to evaluate patients’ electrocardiograms (ECGs) in a targeted strategy to screen for atrial fibrillation, a common heart rhythm disorder
September 29, 2022
AI-guided Screening Uses ECG Data to Detect a Hidden Risk Factor for Stroke
September 29, 2022 — Researchers at Mayo Clinic used artificial intelligence (AI) to evaluate patients’ …
Read More
Higher blood levels of collagen-derived molecule predict worse outcomes
September 29, 2022
Penn Study Identifies New Prognostic Biomarker for Heart Failure
September 29, 2022 — Bloodstream levels of a protein fragment called endotrophin can be used to predict outcomes in…
Read More
The multi-center first-in-men study evaluates the safety and performance of the next generation of BIOTRONIK’s Resorbable Magnesium Scaffold (RMS)
September 28, 2022
BIOMAG-I Clinical Trial Reaches Primary Endpoint at Six Month for Unique Next Generation Resorbable Magnesium Scaffold
September 28, 2022 —  In the "TCT Innovation" session Prof. Michael Haude, BIOMAG-I Coordinating Clinical Investigator…
Read More
Yeonsik Now, UMass Amherst assistant professor who holds a joint appointment in the Elaine Marieb College of Nursing and the College of Engineering’s electrical and computer engineering department, was awarded a projected four-year, $2.3 million grant from the National Institutes of Health’s National Heart, Blood and Lung Institute. Image courtesy of UMass Amherst
September 28, 2022
Wearing a Vest With Wireless Hardware for Five Minutes a Day May Help People With Heart Failure Stay Out of the Hospital
September 28, 2022 —  A University of Massachusetts Amherst nurse engineer is leading a team of researchers who are…
Read More
Draper engineers are developing the Low-force Expanding/Adaptable Pediatric (LEAP) Valve—the first heart valve that can grow with the patient. Credit: Draper
September 28, 2022
Draper Advances Growth-Adaptive Pediatric Heart Valve with Sutureless Adhesive
September 28, 2022 —  Babies born with heart valve defects will have as many as 3 to 5 open heart surgeries before…
Read More
George Washington University Researchers have found that post-stroke language and orientation impairments predicted recurrent stroke, while attention deficit impairment was associated with increased risk of death.
September 28, 2022
New Study Provides Insights into Stroke Recurrence and Death in Patients with Insulin Resistance
September 28, 2022 — George Washington University researchers have found that post-stroke language and orientation…
Read More
Heart disease prevention pioneer Jeremiah Stamler, MD. Photo courtesy of Legacy.com
By Christine Book
September 28, 2022
Spotlight on Heart Disease Prevention Pioneer, Jeremiah Stamler, MD
World Heart Day takes place each year on September 29. Founded in 2000 by the World Heart Federation, World Heart Day…
Read More
Martha Gulati, MD, is the new director of Preventive Cardiology in the Smidt Heart Institute. Photo by Cedars-Sinai.
September 27, 2022
Smidt Heart Institute Welcomes New Director of Preventive Cardiology
September 27, 2022 —  Martha Gulati, MD, an expert in preventive cardiology and women’s heart disease, has joined the…
Read More
Magmaris Scaffold Performs Well in Real World Settings Even in More Complex Patient Groups
September 27, 2022
BIOSOLVE-IV Full-Cohort Two-Year Data Confirm Excellent Safety and Efficacy Profile of Magmaris Resorbable Magnesium Scaffold
September 27, 2022 —  BIOTRONIK announced the presentation of new full-cohort 2-year BIOSOLVE-IV data. In a poster…
Read More
a late breaking abstract describing dose response data from its positive Phase 2 clinical study of istaroxime in early cardiogenic shock (SEISMiC) will be presented on October 2 at the Heart Failure Society of America Annual Scientific Meeting in Washington, DC.
September 27, 2022
Windtree Therapeutics Announces Istaroxime Late Breaker Abstract from its Positive Phase 2 Study in Early Cardiogenic Shock (SEISMiC) to be Presented at Heart Failure Society of America
September 27, 2022 —  Windtree Therapeutics, Inc., a biotechnology company focused on advancing multiple late-stage…
Read More
Edwards Lifesciences announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards' breakthrough RESILIA tissue technology with the industry-leading SAPIEN 3 Ultra transcatheter aortic heart valve.
September 26, 2022
Edwards Launches Sapien 3 Ultra Resilia Valve Following FDA Approval
September 26, 2022 — Edwards Lifesciences announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates…
Read More
UC San Diego researchers have created the first diagnostic tool able differentiate between two similar pediatric inflammatory conditions, using a novel artificial intelligence-guided algorithm
September 26, 2022
How to Tell the Difference between Kawasaki Disease and MIS-C
September 26, 2022 — Kawasaki disease (KD) is the leading cause of acquired heart disease in children in developed…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now